Publicaciones en las que colabora con María de la Fuente (13)

2018

  1. Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)

    PLoS ONE, Vol. 13, Núm. 10

2017

  1. Allogeneic blood-based therapies: Hype or hope?

    Eye (Basingstoke)

2016

  1. Biological effects of plasma rich in growth factors (PRGF) on human endometrial fibroblasts

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 206, pp. 125-130

  2. Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration

    Platelets, Vol. 27, Núm. 5, pp. 459-466

  3. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model

    Experimental Eye Research, Vol. 151, pp. 115-121

  4. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases

    Current Eye Research, Vol. 41, Núm. 7, pp. 875-882

2015

  1. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts

    Experimental Eye Research, Vol. 135, pp. 118-126

  2. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops after Their Different Time and Temperature Conditions of Storage

    Cornea, Vol. 34, Núm. 9, pp. 1144-1148

2014

  1. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop

    Experimental Eye Research, Vol. 119, pp. 27-34

2012

  1. Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid

    Knee Surgery, Sports Traumatology, Arthroscopy, Vol. 20, Núm. 9, pp. 1657-1665

2011

  1. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-β1-induced myodifferentiation

    Investigative Ophthalmology and Visual Science, Vol. 52, Núm. 9, pp. 6066-6073

2009

  1. Fibroblastic response to treatment with different preparations rich in growth factors

    Cell Proliferation, Vol. 42, Núm. 2, pp. 162-170

2006

  1. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities

    Journal of Biomedical Materials Research - Part A, Vol. 77, Núm. 2, pp. 285-293